相关实验视频

Updated: Jan 10, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

一个特定于种群的PARP1基因变异调节了PARP捕获

Jin Cai^1,2, Ramya Billur³, Michael S Cohen⁴

¹Department of Physiological Chemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, 82152 Martinsried, Germany.

bioRxiv : the preprint server for biology

|November 26, 2025

概括

在人体中常见的一种PARP1聚合酶的基因变异显著影响了PARP抑制剂 (如Talazoparib) 的作用. 这一发现表明,基于PARP1遗传特征的个性化癌症疗法可以提高疗效和安全性.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

聚ADP-ribose聚合酶抑制剂 (PARPi) 在癌症治疗中至关重要,特别是在同源重组缺陷 (HRD) 癌症中.
PARPi通过抑制PARP1来起作用,但它们的有效性因在受损DNA上保留PARP1的差异而有所不同.
涉及螺旋域不稳定性的PARP1的Allosteric激活是染色质保留和合成致死性的关键.

研究的目的:

调查PARP1螺旋域 (HD) 中常见的人类多态性对临床PARPi talazoparib的疗效的影响.
阐明talazoparib与不同PARP1变体相互作用的机制差异.

主要方法:

在PARP1 HD中利用了人类常见的多态性.
在癌症模型中分析了talazoparib对PARP1保留,XRCC1招募和细胞杀伤的影响.
根据PARP1基因型,将talazoparib的行为描述为I型或II型PARPi.

主要成果:

一种特定的PARP1变体 (PARP1^V762) 显著增强了talazoparib诱导的染色质上的全性保留.
与野生型PARP1^A762相比,这种增强的保留导致了长时间的XRCC1招募和增加的癌细胞杀伤.
在PARP1^V762变种的存在下,Talazoparib从II型转变为支持保留的I型行为.

结论:

PARPi的疗效和耐受性受到患者特定的PARP1等位基因的影响.
这突显了变异导向癌症疗法的潜力,以优化治疗结果.
了解PARP1多态性对于开发更有效,更安全的基于PARPi的治疗方法至关重要.

更多相关视频

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

相关概念视频

Long-patch Base Excision Repair

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...